Howard Hughes Medical Investigators

Life Edit Therapeutics Announces Newly Established Scientific Advisory Board

Retrieved on: 
Thursday, July 8, 2021
Biotechnology, Pharmaceutical, Genetics, Health, Branches of biology, Genome editing, Biology, Genetics, Genome, Howard Hughes Medical Investigators, Genetic engineering, Emerging technologies, Atlas Venture

Life Edit Therapeutics Inc., an ElevateBio portfolio company focused on next-generation genome-editing, today announced initial members of its newly-formed Scientific Advisory Board (SAB).

Key Points: 
  • Life Edit Therapeutics Inc., an ElevateBio portfolio company focused on next-generation genome-editing, today announced initial members of its newly-formed Scientific Advisory Board (SAB).
  • As we continue to build our pipeline of novel gene-editing tools and further strengthen our gene-editing expertise, we are honored to have the opportunity to work alongside this highly-esteemed Scientific Advisory Board with specialized gene-editing leadership.
  • He serves as an Independent Board member at KromaTid, Inc, an advisor to the NIH Somatic Cell Genome Editing Consortium, and a SAB member of Obsidian Therapeutics.
  • About Life Edit Therapeutics Inc.
    Life Edit Therapeutics, an ElevateBio portfolio company, is a next-generation genome editing company that has built a highly innovative platform with one of the worlds largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors.

Decibel Therapeutics Expands World-Class Scientific Advisory Board

Retrieved on: 
Monday, May 24, 2021
Howard Hughes Medical Investigators, Phillip D. Zamore

Career summaries of the Scientific Advisory Board appointees:

Key Points: 
  • Career summaries of the Scientific Advisory Board appointees:
    Connie Cepko, Ph.D., is the Bullard Professor of Genetics and Neuroscience at Harvard Medical School and a Howard Hughes Medical Institute Investigator.
  • Dr. Gao co-founded Voyager Therapeutics, Adrenas Therapeutics and Aspa Therapeutics to develop AAV-based gene therapies for rare diseases.
  • Most recently, she was Chief Scientific Officer at Voyager Therapeutics, joining soon after its start in 2014.
  • For more information about Decibel Therapeutics, please visit www.decibeltx.com or follow us on Twitter .

Cellino CEO Dr. Nabiha Saklayen Awarded Inaugural Tory Burch Fellowship at the Innovative Genomics Institute

Retrieved on: 
Thursday, May 20, 2021
Health, Technology, Other Technology, Other Science, General Health, Research, Science, Awards, Howard Hughes Medical Investigators, Tory Burch, Igi, Jennifer Doudna, Fashion, Burch, Science and technology awards, the Tory Burch Foundation, the Innovative Genomics Institute, Cellino, THE TORY BURCH FOUNDATION, THE INNOVATIVE GENOMICS INSTITUTE, CELLINO

b'Cellino , a personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, today announced that its CEO Dr. Nabiha Saklayen has been awarded the first Tory Burch Fellowship at the International Genomics Institute (IGI).\nThis press release features multimedia.

Key Points: 
  • b'Cellino , a personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, today announced that its CEO Dr. Nabiha Saklayen has been awarded the first Tory Burch Fellowship at the International Genomics Institute (IGI).\nThis press release features multimedia.
  • They face the same barriers that women entrepreneurs typically face, including limiting stereotypes and a lack of access to capital, education and networks.
  • This Fellowship program is the Tory Burch Foundation\xe2\x80\x99s first contribution to the vital issue of women in STEM and we could not be more thrilled to be partnering with brilliant, trailblazing Jennifer Doudna and the Innovative Genomics Institute,\xe2\x80\x9d said Tory Burch, CEO at Tory Burch.\n"Part of our mission at the Innovative Genomics Institute is to be the bridge from research to real-world impact,\xe2\x80\x9d said Dr. Doudna.
  • We are delighted to partner with the Tory Burch Foundation and welcome Dr. Saklayen as our first fellow.\xe2\x80\x9d\n\xe2\x80\x9cI am honored to receive the first Tory Burch Fellowship at the IGI and have Nobel Prize Laureate Dr. Jennifer Doudna and leading designer and entrepreneur Tory Burch as mentors,\xe2\x80\x9d said Nabiha Saklayen, Ph.D., CEO and Co-Founder at Cellino.

2021 FNIH Lurie Prize in Biomedical Sciences Winner Revolutionized Imaging to Reveal Structures Hidden in Cells

Retrieved on: 
Thursday, April 15, 2021
Howard Hughes Medical Investigators, Lurie Prize in Biomedical Sciences, National Institutes of Health, Foundation for the National Institutes of Health, Xiaowei Zhuang, Microscopy, Science and technology in the United States, Optics, Physical sciences, Super-resolution microscopy

b'NORTH BETHESDA, Md., April 15, 2021 /PRNewswire/ --The Foundation for the National Institutes of Health (FNIH) has named Xiaowei Zhuang, Ph.D., winner of the 2021 Lurie Prize in Biomedical Sciences for pioneering the development of super-resolution microscopy and genome-scale imaging showing new spatial and functional organizations of molecules and cells.

Key Points: 
  • b'NORTH BETHESDA, Md., April 15, 2021 /PRNewswire/ --The Foundation for the National Institutes of Health (FNIH) has named Xiaowei Zhuang, Ph.D., winner of the 2021 Lurie Prize in Biomedical Sciences for pioneering the development of super-resolution microscopy and genome-scale imaging showing new spatial and functional organizations of molecules and cells.
  • How precisely these structures can be defined is limited by the physical properties of light itself, the so-called diffraction limit of light.
  • "\nNow in its ninth year, the Lurie Prize in Biomedical Sciences recognizes outstanding achievement by a promising scientist aged 52 or younger.
  • "\nA jury of six distinguished biomedical researchers selected Dr. Zhuang as this year\'s Lurie Prize in Biomedical Sciences recipient.

CBC Group Announces the Appointment of Roger Perlmutter as Science Partner

Retrieved on: 
Monday, March 15, 2021
Howard Hughes Medical Investigators, Canadian Broadcasting Corporation, Department of Canadian Heritage, Roger M. Perlmutter, Perlmutter, Government, Canadian culture, Canada

SHANGHAI, March 15, 2021 /PRNewswire/ -- CBC Group ("CBC"), a healthcare-dedicated investment firm, is pleased to announce thatRoger M. Perlmutter, M.D., Ph.D., currently non-Executive Chairman,Merck Research Laboratories, joins CBC as Science Partner and a member of its Scientific Advisory Board.

Key Points: 
  • SHANGHAI, March 15, 2021 /PRNewswire/ -- CBC Group ("CBC"), a healthcare-dedicated investment firm, is pleased to announce thatRoger M. Perlmutter, M.D., Ph.D., currently non-Executive Chairman,Merck Research Laboratories, joins CBC as Science Partner and a member of its Scientific Advisory Board.
  • "I am thrilled to have Dr. Perlmutter on board," Fu Wei, CEO of CBC Group, said.
  • "I am delighted to join the CBC Group as a Science Partner and a member of its Scientific Advisory Board, and to assist them in advancing innovative biotechnologythroughout Asia."
  • Founded in 2014, CBC Group has a strong team of investment, healthcare and portfolio management professionals based acrossSingapore,Shanghai,Beijing,Hong KongandNew York.

NRL physicist earns 2020 AAAS Newcomb Cleveland Prize

Retrieved on: 
Tuesday, March 2, 2021
Articles, Astronomy, Science and technology, Fast radio burst, Radio astronomy, Search for extraterrestrial intelligence, Unexplained Phenomena, American Association for the Advancement of Science, Newcomb Cleveland Prize, Howard Hughes Medical Investigators

For their research, Kerr and the team were recognized by the 2020 American Association for the Advancement of Science Newcomb Cleveland Prize for a discovery that improved the understanding of FRBs in distant galaxies.

Key Points: 
  • For their research, Kerr and the team were recognized by the 2020 American Association for the Advancement of Science Newcomb Cleveland Prize for a discovery that improved the understanding of FRBs in distant galaxies.
  • Kerr said the international team and NRL team really made this prize possible.
  • The Newcomb Cleveland Prize, American Association for the Advancement of Science's oldest award, recognizes the author or authors of an outstanding paper published in the Research Articles or Reports sections of Science.
  • Tags/Key Words: VLITE; American Association for the Advancement of Science Newcomb Cleveland Prize; AAAS; Newcomb Cleveland Prize; fast radio burst; FRB; NRL; VLA

Eric Lander to take an academic leave to serve as White House science advisor; Board of Directors appoints Todd Golub as director of Broad Institute

Retrieved on: 
Friday, January 15, 2021
Harvard Medical School, Howard Hughes Medical Investigators, Todd Golub, Broad Institute, Golub, Massachusetts, Dana–Farber Cancer Institute, Farber, Ivy League, Science and technology in the United States

The Board of Directors has appointed Todd R. Golub , the Broad's Chief Scientific Officer, as Director of the Broad Institute.

Key Points: 
  • The Board of Directors has appointed Todd R. Golub , the Broad's Chief Scientific Officer, as Director of the Broad Institute.
  • He is also the Charles A. Dana Investigator in Human Cancer Genetics at the Dana-Farber Cancer Institute and professor of pediatrics at Harvard Medical School.
  • "Broad is in a stronger scientific and cultural position today than at any point in our 16-year history," Golub said.
  • "Moreover, the pandemic has pushed us to think differently about nearly every aspect of how we collaborate and deliver on our scientific mission.

Appointment of Professor Akiko Iwasaki to Scientific Advisory Board

Retrieved on: 
Friday, December 18, 2020
Howard Hughes Medical Investigators, Akiko Iwasaki, Immunity, Immunology, Medicine, Health

Brings extensive experience in Immunology within the field of infectious diseases, most recently in COVID-19

Key Points: 
  • Brings extensive experience in Immunology within the field of infectious diseases, most recently in COVID-19
    LONDON & BOSTON 4BIO Capital (4BIO or the Group), an international venture capital firm focused solely on the advanced therapies sector, announces the appointment of Professor Akiko Iwasaki to its Scientific Advisory Board (SAB).
  • Professor Iwasaki has made significant contributions towards understanding innate and adaptive immunity.
  • Dmitry Kuzmin, Managing Partner at 4BIO Capital, said: We are delighted to welcome Professor Iwasaki to 4BIOs Scientific Advisory Board.
  • Professor Akiko Iwasaki said: I am excited to join 4BIOs Scientific Advisory Board.

Appointment of Professor Akiko Iwasaki to Scientific Advisory Board

Retrieved on: 
Friday, December 18, 2020
Howard Hughes Medical Investigators, Akiko Iwasaki, Immunity, Immunology, Medicine, Health

Brings extensive experience in Immunology within the field of infectious diseases, most recently in COVID-19

Key Points: 
  • Brings extensive experience in Immunology within the field of infectious diseases, most recently in COVID-19
    LONDON & BOSTON 4BIO Capital (4BIO or the Group), an international venture capital firm focused solely on the advanced therapies sector, announces the appointment of Professor Akiko Iwasaki to its Scientific Advisory Board (SAB).
  • Professor Iwasaki has made significant contributions towards understanding innate and adaptive immunity.
  • Dmitry Kuzmin, Managing Partner at 4BIO Capital, said: We are delighted to welcome Professor Iwasaki to 4BIOs Scientific Advisory Board.
  • Professor Akiko Iwasaki said: I am excited to join 4BIOs Scientific Advisory Board.

Impossible Foods Hires Vanderbilt University Biochemistry Department Chair Dr. John D. York as Chief Science Officer

Retrieved on: 
Tuesday, December 8, 2020
Technology, Supermarket, Other Science, Food, Beverage, Environment, Research, Retail, Restaurant, Bar, Fitness & Nutrition, University, Biotechnology, Education, Other Consumer, Health, Women, MEN, General Health, Agriculture, Family, Science, Natural Resources, Other Technology, Consumer, Howard Hughes Medical Investigators, Impossible Foods, Food and drink, California, States of the United States

Impossible Foods announced today the hiring of Vanderbilt University Biochemistry Department Chair Dr. John D. York, Ph.D. as Chief Science Officer at the worlds leading food technology startup.

Key Points: 
  • Impossible Foods announced today the hiring of Vanderbilt University Biochemistry Department Chair Dr. John D. York, Ph.D. as Chief Science Officer at the worlds leading food technology startup.
  • Under Yorks leadership, Impossible Foods will continue to build its food technology platform and expand basic research capabilities to accelerate next-generation products.
  • York, a former Investigator for the Howard Hughes Medical Institute, has led the Department of Biochemistry at Vanderbilt University since 2012.
  • Impossible Foods was Inc. Magazines company of the year and one of Time Magazines 50 Genius companies .